139 related articles for article (PubMed ID: 9834001)
41. Inhibitory effect of a long-acting somatostatin analogue on EGF-stimulated cell proliferation in Capan-2 cells.
Burghardt B; Barabás K; Marcsek Z; Flautner L; Gress TM; Varga G
J Physiol Paris; 2000; 94(1):57-62. PubMed ID: 10761690
[TBL] [Abstract][Full Text] [Related]
42. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
Pandya PK; Huang SC; Talkad VD; Wank SA; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):117-26. PubMed ID: 7948036
[TBL] [Abstract][Full Text] [Related]
43. Direct demonstration of three different states of the pancreatic cholecystokinin receptor.
Talkad VD; Fortune KP; Pollo DA; Shah GN; Wank SA; Gardner JD
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1868-72. PubMed ID: 8127897
[TBL] [Abstract][Full Text] [Related]
44. Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth.
Kaufmann R; Schafberg H; Rudroff C; Henklein P; Nowak G
Neuropeptides; 1997 Dec; 31(6):573-83. PubMed ID: 9574824
[TBL] [Abstract][Full Text] [Related]
45. Transfected cholecystokinin receptors mediate growth inhibitory effects on human pancreatic cancer cell lines.
Detjen K; Fenrich MC; Logsdon CD
Gastroenterology; 1997 Mar; 112(3):952-9. PubMed ID: 9041258
[TBL] [Abstract][Full Text] [Related]
46. Cholecystokinin octapeptide induces both proliferation and apoptosis in the rat pancreas.
Trulsson LM; Svanvik J; Permert J; Gasslander T
Regul Pept; 2001 Apr; 98(1-2):41-8. PubMed ID: 11179777
[TBL] [Abstract][Full Text] [Related]
47. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
48. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro.
Logsdon CD
Am J Physiol; 1986 Oct; 251(4 Pt 1):G487-94. PubMed ID: 3020992
[TBL] [Abstract][Full Text] [Related]
49. The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.
Sarri E; Ramos B; Salido GM; Claro E
Br J Pharmacol; 2001 Aug; 133(8):1227-34. PubMed ID: 11498507
[TBL] [Abstract][Full Text] [Related]
50. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
51. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
[TBL] [Abstract][Full Text] [Related]
52. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells.
Dabrowski A; Detjen KM; Logsdon CD; Williams JA
Digestion; 1997; 58(4):361-7. PubMed ID: 9324163
[TBL] [Abstract][Full Text] [Related]
53. Effect of food restriction on plasma cholecystokinin levels and exocrine pancreatic function in rats.
Chowdhury P; Rayford PL
Ann Clin Lab Sci; 2001 Oct; 31(4):376-82. PubMed ID: 11688849
[TBL] [Abstract][Full Text] [Related]
54. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
Ferris HA; Tapia JA; García LJ; Jensen RT
Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
[TBL] [Abstract][Full Text] [Related]
55. Binding of a phenethyl ester analogue of cholecystokinin to the solubilized pancreatic cholecystokinin receptor: use in ligand-affinity chromatography.
Miller LJ; Hadac EM; Gates LK; Gaisano HY
Biochem Biophys Res Commun; 1992 Mar; 183(2):396-404. PubMed ID: 1550549
[TBL] [Abstract][Full Text] [Related]
56. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
[TBL] [Abstract][Full Text] [Related]
57. Characterization of cholecystokinin receptors on guinea pig gastric chief cell membranes.
Matozaki T; Sakamoto C; Nagao M; Nishisaki H; Konda Y; Nakano O; Matsuda K; Wada K; Suzuki T; Kasuga M
Biochem Biophys Res Commun; 1991 Feb; 174(3):1055-63. PubMed ID: 1996975
[TBL] [Abstract][Full Text] [Related]
58. Suppression of Ca2+ oscillations induced by cholecystokinin (CCK) and its analog OPE in rat pancreatic acinar cells by low-level protein kinase C activation without transition of the CCK receptor from a high- to low-affinity state.
Gaisano HY; Miller LJ; Foskett JK
Pflugers Arch; 1994 Jul; 427(5-6):455-62. PubMed ID: 7971144
[TBL] [Abstract][Full Text] [Related]
59. Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy.
Caplin ME; Clarke P; Grimes S; Dhillon AP; Khan K; Savage K; Lewin J; Michaeli D; Pounder RE; Watson SA
Regul Pept; 1999 Oct; 84(1-3):81-9. PubMed ID: 10535412
[TBL] [Abstract][Full Text] [Related]
60. Secretory response of cultured acinar cells of rat pancreas to cholecystokinin.
Kim H; Kim KH
Yonsei Med J; 1996 Dec; 37(6):405-11. PubMed ID: 9048493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
